Publications by authors named "Jacob B Stocks"

Background: Digital storytelling (DST) encourages participants to use technology to create narratives and share personal experiences. Although DST can amplify the voices of groups experiencing marginalization, it is unclear how DST has been used among young adults of color. We also lack a comprehensive understanding of DST's role in addressing health-related outcomes.

View Article and Find Full Text PDF

During the COVID-19 pandemic, rapid changes in variant virulence, limited personal protective equipment availability, and diminished hospital capacity necessitated aggressive vaccine distribution. To promote COVID-19 vaccination to historically underserved populations, the National Institutes of Health funded a small group of clinical trials, including the Tough Talks for COVID-19 vaccine (TT-C) digital health intervention (DHI) randomized controlled trial (RCT). Black young adults, 18-29 years, who were unvaccinated or insufficiently vaccinated against COVID-19 were recruited via social media in Alabama, Georgia, and North Carolina and randomized to the intervention or standard of care control (N = 360).

View Article and Find Full Text PDF

Background: In 2022, 3100 adolescent girls and young women in sub-Saharan Africa experienced new HIV infections each week. HIV pre-exposure prophylaxis (PrEP) is effective at preventing HIV but has limited uptake and persistence. Mobile health (mHealth) interventions can improve medication adherence; however, their utility to improve PrEP adherence among adolescent girls and young women is not well established.

View Article and Find Full Text PDF

We compared self-reported vaccination to vaccine card data to assess concurrency in a sample of Black young adults in Georgia, Alabama, and North Carolina. We described vaccine card versus self-reported data over time and examined discrepancies in reporting between these two sources. Results indicated strong currency suggesting collection of self-reported data may be an acceptable proxy to requiring official vaccine documentation.

View Article and Find Full Text PDF

Background: Negative attitudes toward vaccines and suboptimal vaccination rates among African American and Black (Black) Americans have been well documented, due to a history of medical racism and human rights violations in the United States. However, digital health interventions (DHI) have been shown to address racial disparities in several health outcomes, such as cardiovascular disease, HIV, and maternal health. The Tough Talks COVID (TT-C) study was a randomized controlled trial of a DHI designed to empower Black young adults in the United States South to make informed, autonomous decisions about COVID-19 vaccine uptake by addressing structural barriers and misinformation about vaccines.

View Article and Find Full Text PDF

Background: While access to pre-exposure prophylaxis (PrEP) is an important tool for reducing HIV incidence in the United States, disparities in uptake by race, sex, socioeconomic status, and geography persist. In 2018, the US South accounted for more than half of all new HIV diagnoses but only one-third of PrEP users. PrEP use in North Carolina (NC) similarly lags, with uptake being the lowest among young, sexual and gender minority populations, who account for nearly two-thirds of the state's incident infections.

View Article and Find Full Text PDF

The population-level reductions in HIV incidence attributed to pre-exposure prophylaxis (PrEP) have not been fully realized among sexual, gender, and racial/ethnic minority youth. P3 (Prepared, Protected, emPowered) is a comprehensive mobile application (app) intervention developed to support PrEP adherence through gamification, medication tracking, and social engagement. A randomized controlled trial was conducted with 246 young men who have sex with men (YMSM) and young transgender women who have sex with men (YTWMSM) currently on or planning to begin PrEP.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to assess mpox knowledge among Black young adults (ages 18-29) in Alabama, Georgia, and North Carolina to better target public health efforts.
  • Results showed a wide range of correct responses to mpox knowledge questions (26%-96%), with 26% unaware of the vaccine and 21% mistakenly believing the chickenpox vaccine offered protection against mpox.
  • Females generally had better knowledge than males, and no significant differences were found between states, indicating the need for regional educational initiatives to fill knowledge gaps and improve public health preparedness.
View Article and Find Full Text PDF
Article Synopsis
  • The study developed and validated two brief measurement scales: the Mpox Stigma Scale (MSS) and the Mpox Knowledge Scale (MKS) to address knowledge and stigma as barriers to mpox-related care and prevention.
  • Conducted with 330 self-identified African American or Black participants aged 18-29 in Alabama, Georgia, or North Carolina, the study confirmed the psychometric properties of both scales using various statistical analyses.
  • Results demonstrated that the MSS and MKS showed strong reliability and valid correlations with stigmatizing attitudes, attitudes towards vaccination, and concerns about contracting mpox, emphasizing the importance of understanding stigma and knowledge in public health strategies.
View Article and Find Full Text PDF

This study quantitatively examined factors related to young men who have sex with men (YMSM)'s decisions to use pre-exposure prophylaxis (PrEP) by their history of PrEP use and qualitatively elicited their perspectives on PrEP options. Higher proportions of YMSM who had never used (vs. ever used) PrEP considered the following factors as important in their decisions to use PrEP: (a) Returning to PrEP follow-up visits ( p = .

View Article and Find Full Text PDF
Article Synopsis
  • The study emphasizes the urgent need for tailored interventions to improve PrEP uptake among young sexual and gender minority youth (SGMY) to help end the HIV epidemic by 2030.
  • It includes a three-phase approach: first, formative research to gather insights from key informants and SGMY; second, usability testing with SGMY to assess the intervention's content and delivery; and third, a pilot trial involving 150 SGMY to evaluate the intervention's feasibility and acceptability.
  • The ultimate goal is to enhance patient activation and navigation in accessing PrEP, aiming for better health outcomes in a racially and ethnically diverse population in Los Angeles.
View Article and Find Full Text PDF